Pfizer Research and Development Expenses 2010-2024 | PFE

Pfizer research and development expenses for the twelve months ending December 31, 2024 were $10.822B, a 1.34% increase year-over-year.

  • Pfizer annual research and development expenses for 2024 were $10.822B, a 1.34% increase from 2023.
  • Pfizer annual research and development expenses for 2023 were $10.679B, a 6.55% decline from 2022.
  • Pfizer annual research and development expenses for 2022 were $11.428B, a 10.31% increase from 2021.

Pfizer Research and Development Expenses 2010-2024 | PFE

  • Pfizer annual research and development expenses for 2024 were $10.822B, a 1.34% increase from 2023.
  • Pfizer annual research and development expenses for 2023 were $10.679B, a 6.55% decline from 2022.
  • Pfizer annual research and development expenses for 2022 were $11.428B, a 10.31% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B